Medifast, Inc.

NYSE:MED

Personal Products & Services

Consumer Cyclical
$12.20 -0.04%

-$0.01 today

Market cap
$136.43M
Beta
0.66
P/E (TTM)
-6.2
EPS (TTM)
-$1.82
52W Low $9.22High $15.46

Volume 0.09M

Average 0.21M

Returns on capital

Medifast, Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-9.4%

avg 42.9%

ROIC

-6.5%

avg 38.8%

ROA

-7.3%

avg 24.8%

Analysis

ROIC is currently the strongest return metric at -6.5% versus its period average of 38.8%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

James Maloney

Chief Financial OfficerUSD 727.97K58——

Nicholas Johnson

CEO & PresidentUSD 610.46K46——

Matthew Daryman

Manager of Investor Relations————

Steven Zenker

Vice President of Investor Relations————

Claudia C. Greninger

Chief Human Resources Officer—52——

Jonathan Barrett MacKenzie

Vice President of Finance & Chief Accounting Officer—5410.01K0.09%

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Mar 25, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

14

$1.74M

Sells

2

$226,288.77

Net Transaction Value

+$1.52M

Net buying

Most Active

Kiai Parsa

11 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Nov 4, 26

Kiai Parsa

Indirect

Buy$8.6K
Oct 28, 26

Kiai Parsa

Indirect

Buy$1.9K
Oct 28, 26

Kiai Parsa

Indirect

Buy$66.1K
Sep 29, 26

Chard Daniel R

Indirect

Sell$112K
Sep 28, 26

Chard Daniel R

Indirect

Sell$114.3K
Aug 26, 26

Kiai Parsa

Indirect

Buy$14.4K
Aug 26, 26

Kiai Parsa

Indirect

Buy$514.7K
Aug 24, 26

Kiai Parsa

Indirect

Buy$50.5K
Aug 24, 26

Kiai Parsa

Indirect

Buy$1.4K
Aug 20, 26

Kiai Parsa

Indirect

Buy$487.1K

1–10 of 16

Summary

Insiders reported 14 buys worth $1.74M and 2 sells worth $226,288.77 over the last 12 months. That adds up to net buying of $1.52M. Kiai Parsa was the most active insider with 11 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/A-37.7%
-15.6% (2yr)1 analysts
Net IncomeN/AN/AN/A
N/A1 analysts
EBITN/AN/AN/A
N/A1 analysts

Analysis

Recent growth has been strongest in Revenue at -37.7% over three years. Forward estimates point to Revenue at -15.6% (2yr), giving you a quick check on whether expectations are accelerating or cooling.

Competitors

Who does Medifast, Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about MED's management, answered from reported figures.

Who manages MED?

Medifast, Inc. (MED) lists 6 active executives. The top listed executive is James Maloney, Chief Financial Officer.

Are MED insiders buying or selling?

Recent insider activity shows net selling of $5.53M.